See more : Fancl Corporation (4921.T) Income Statement Analysis – Financial Results
Complete financial analysis of Jupiter Wellness, Inc. (JUPW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jupiter Wellness, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- AGBA Acquisition Limited (AGBAR) Income Statement Analysis – Financial Results
- Oranco, Inc. (ORNC) Income Statement Analysis – Financial Results
- Rekor Systems, Inc. (REKR) Income Statement Analysis – Financial Results
- Rent the Runway, Inc. (RENT) Income Statement Analysis – Financial Results
- China Minsheng Banking Corp., Ltd. (CGMBF) Income Statement Analysis – Financial Results
Jupiter Wellness, Inc. (JUPW)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jupiterwellness.com
About Jupiter Wellness, Inc.
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 6.20M | 2.88M | 1.07M | 6.46K |
| Cost of Revenue | 5.17M | 2.34M | 624.57K | 18.02K |
| Gross Profit | 1.03M | 535.49K | 441.10K | -11.57K |
| Gross Profit Ratio | 16.56% | 18.62% | 41.39% | -179.23% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 12.52M | 17.31M | 5.58M | 908.72K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 12.52M | 17.31M | 5.58M | 908.72K |
| Other Expenses | 1.54K | 699.70K | 0.00 | 0.00 |
| Operating Expenses | 12.52M | 17.31M | 5.58M | 908.72K |
| Cost & Expenses | 17.69M | 19.65M | 6.20M | 926.74K |
| Interest Income | 1.72K | 7.32K | 3.04K | 1.38K |
| Interest Expense | 1.29M | 1.74M | 116.80K | 6.56K |
| Depreciation & Amortization | 520.81K | 187.92K | 161.37K | 171.86K |
| EBITDA | -10.97M | -16.58M | -4.97M | -918.91K |
| EBITDA Ratio | -176.99% | -576.30% | -466.44% | -14,235.55% |
| Operating Income | -11.49M | -16.76M | -5.13M | -918.91K |
| Operating Income Ratio | -185.39% | -582.83% | -481.59% | -14,235.55% |
| Total Other Income/Expenses | -3.73M | -5.71M | -1.15M | -5.18K |
| Income Before Tax | -15.22M | -28.10M | -6.29M | -925.46K |
| Income Before Tax Ratio | -245.66% | -976.97% | -590.17% | -14,337.13% |
| Income Tax Expense | 2.45M | 1.74M | 116.80K | 6.56K |
| Net Income | -17.67M | -29.84M | -6.41M | -932.02K |
| Net Income Ratio | -285.17% | -1,037.33% | -601.13% | -14,438.71% |
| EPS | -0.80 | -1.80 | -0.87 | -0.12 |
| EPS Diluted | -0.80 | -1.80 | -0.87 | -0.12 |
| Weighted Avg Shares Out | 22.11M | 16.60M | 7.33M | 7.83M |
| Weighted Avg Shares Out (Dil) | 22.11M | 16.60M | 7.33M | 7.83M |
Jupiter Wellness to Support Growth in CBD-Based Pharma & Consumer Products
Jupiter Wellness' SRM Division Sees Significant Monthly Sales Growth as Global Theme Parks Set to Reopen
Jupiter Wellness Launches New Consumer Products Website: www.cbdcaring.com
JUPW Stock Price Increases Over 15% Pre-Market: Why It Happened
Source: https://incomestatements.info
Category: Stock Reports